COMPLIANCE/ADHERENCE PUBLICATIONS

  1. Curtis RJ, Larson JC, Delzell E, Brookhart MA, Cadarette SM, Chlebowski R, Judd S, Safford M, Solomon DH and Lacroix AZ. Placebo adherence, clinical outcomes, and mortality in the Women's Health Initiative randomized hormone therapy trials. Medical Care 2011;49(5):427-435.
  2. Solomon DH, Brookhart MA, Tsao P, Sundaresan D, Andrade SE, Mazor K and Yood R. Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule. Osteoporosis International 2011;22(6):1737-43.
  3. Cadarette SM, Solomon DH, Katz JN, Patrick AR and Brookhart MA. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors. Osteoporosis International 2011;22(3):943-54.
  4. Decramer M, Molenberghs G, Liu D, Celli B, Kesten S, Lystig T and Tashkin DP; UPLIFT Investigators. Premature discontinuation during the UPLIFT study. Respiratory Medicine 2011;105:1523-30.
  5. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Yates JC and Jones PW. Bias due to withdrawal in long-term randomized trials in COPD: Evidence from the TORCH study. The Clinical Respiratory Journal 2011;5(1):44-9.
  6. Cadarette SM, Solomon DH, Katz JN, Patrick AR and Brookhart MA. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors. Osteoporosis International 2011;22(3):943-54.
  7. Shrank WH, Choudhry NK, Fischer MA, Avorn J, Powell M, Schneeweiss S, Liberman JN, Dollear T, Brennan TA and Brookhart MA. The epidemiology of prescriptions abandoned at the pharmacy. Annals of Internal Medicine 2010;153(10):633-40.
  8. Cutrona SL, Choudhry NK, Stedman M, Servi A, Liberman JN, Brennan T, Fischer MA, Brookhart MA and Shrank WH. Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review. Journal of General Internal Medicine 2010;25(10):1090-6.
  9. Choudhry NK, Fischer MA, Avorn J, Schneeweiss S, Solomon DH, Berman C, Jan S, Liu J, Lii J, Brookhart MA, Mahoney JJ and Shrank WH. At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Affairs 2010;29(11):1995-2001.
  10. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, Avorn J, Solomon D, Brookhart MA and Choudhry NK. Patient, physician, and payment predictors of statin adherence. Medical Care 2010;48(3):196-202.
  11. Solomon DH, Gleeson T, Iversen M, Avorn J, Brookhart MA, Lii J, Losina E, May F, Patrick A, Shrank WH and Katz JN. A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial. Osteoporosis International 2010;21(1):137-44.
  12. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC and Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009;64(11):939-43.
  13. Choudhry NK, Shrank WH, Levin RL, Lee JL, Jan SA, Brookhart MA and Solomon DH. Measuring concurrent adherence to multiple related medications. American Journal of Managed Care 2009;15(7):457-64.
  14. Dormuth C, Patrick AR, Wright JM and Brookhart MA. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009 119(15):2051-9.
  15. Shrank WH, Gleason PP, Canning C, Walters C, Heaton AH, Jan S, Patrick A, Brookhart MA, Schneeweiss S, Solomon DH, Avorn J and Choudhry NK. Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the target pharmacy label. Journal of General Internal Medicine 2009;24(5):570-8.
  16. Gordon E, Prohaska T, Gallant M and Siminoff L. Adherence to immunosuppression: A prospective diary study. Transplantation Proceedings 2008;39(10):3081-3085.
  17. Brookhart MA, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Patrick AR, Mogun H and Solomon DH. Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. American Journal of Medicine 2007;120(3):251-6.
  18. Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM and Solomon DH. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. American Journal of Epidemiology 2007;166(3):348-54.
  19. Brookhart MA, Patrick AR, Schneeweiss S, Avorn J, Dormuth C, Shrank W, van Wijk BL, Cadarette SM, Canning CF and Solomon DH. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Archives of Internal Medicine 2007;167(8):847-52.
  20. McCullough L. Factors that facilitate adherence to a 12-week walking intervention among breast cancer survivors. Vanderbilt-Ingram Cancer Center Retreat, Vanderbilt University, Nashville, TN, May 2007.
  21. McCullough L. Factors that facilitate adherence to a 12-week walking intervention among breast cancer survivors. Meharry Medical College, Nashville, TN, March 2007.
  22. Gately R, Hartman T, Kamas G and Nguyen T. The impact of diabetes health education on medication adherence and inpatient utilization. Gerontological Society of America, Dallas, TX, 2006.
  23. Campione J, Sleath B, Biddle A and Weinberger M. The influence of physician guideline compliance on patient statin adherence. The American Journal of Geriatric Pharmacotherapy 2005;3(4):229-239.
  24. Chandran L, Navaie-Waliser M, Querishi N, Batra S, Bayir H and Shah M. Physician compliance with group B Streptococcal disease prevention guidelines. American Journal of Maternal and Child Nursing 2001;26(6):313-319.